Co-Authors
This is a "connection" page, showing publications co-authored by Fernando Bozza and Thiago Souza.
Connection Strength
1.521
-
COVID-19 hospital admissions: Brazil's first and second waves compared. Lancet Respir Med. 2021 08; 9(8):e82-e83.
Score: 0.239
-
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother. 2021 06 18; 76(7):1874-1885.
Score: 0.238
-
Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 May 19; 7(1):116.
Score: 0.237
-
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil. Emerg Infect Dis. 2021 May; 27(5):1446-1453.
Score: 0.235
-
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 Mar 01; 7(1):43.
Score: 0.233
-
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Antimicrob Agents Chemother. 2020 09 21; 64(10).
Score: 0.226
-
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020 12; 16(12):e1009127.
Score: 0.057
-
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020 09 10; 136(11):1330-1341.
Score: 0.056